These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9613135)

  • 1. [Prognostic significance of alterations in telomeric repeat length in patients with pathological stage I-II non-small cell lung cancer].
    Hirashima T; Komiya T; Nitta T; Kobayashi M; Kawase I
    Nihon Rinsho; 1998 May; 56(5):1264-71. PubMed ID: 9613135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer.
    Hirashima T; Komiya T; Nitta T; Takada Y; Kobayashi M; Masuda N; Matui K; Takada M; Kikui M; Yasumitu T; Ohno A; Nakagawa K; Fukuoka M; Kawase I
    Anticancer Res; 2000; 20(3B):2181-7. PubMed ID: 10928174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
    Hsu CP; Miaw J; Shai SE; Chen CY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
    Lin X; Gu J; Lu C; Spitz MR; Wu X
    Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
    Hsu CP; Ko JL; Shai SE; Lee LW
    Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
    Wang J; Liu X; Jiang W; Liang L
    Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
    Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
    Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer].
    Jassem E; Rosell R; Jassem J; Monzo M; Kobierska G; Badzio A; Roszkiewicz A; Skokowski J; Szulc A
    Pneumonol Alergol Pol; 1998; 66(5-6):290-6. PubMed ID: 9857649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of flow cytometry in non-small-cell lung cancer.
    Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
    Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
    Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere length variation and maintenance in hepatocarcinogenesis.
    Yokota T; Suda T; Igarashi M; Kuroiwa T; Waguri N; Kawai H; Mita Y; Aoyagi Y
    Cancer; 2003 Jul; 98(1):110-8. PubMed ID: 12833463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere length, telomeric proteins and DNA damage repair proteins are differentially expressed between primary lung tumors and their adrenal metastases.
    Raynaud CM; Mercier O; Commo F; Dartevelle P; Gomez-Roca C; de Montpreville V; Sabatier L; Soria JC
    Lung Cancer; 2009 Aug; 65(2):144-9. PubMed ID: 19091442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH; Li J; Shi SB; Yu LC; Ge LP; Chen P
    Jpn J Clin Oncol; 2010 Apr; 40(4):327-35. PubMed ID: 20056675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.
    Tseden-Ish M; Choi YD; Cho HJ; Ban HJ; Oh IJ; Kim KS; Song SY; Na KJ; Ahn SJ; Choi S; Kim YC
    Respirology; 2012 Jan; 17(1):127-33. PubMed ID: 21899657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.